Belgian Biotech Ablynx Raises $200M In Upsized IPO
Belgian biotechnology company Ablynx NV said Wednesday it raised $200 million in an upsized U.S. initial public offering, completing a cross-border deal that engaged the services of four law firms....To view the full article, register now.
Already a subscriber? Click here to view full article